SCHEMBL19397402

SCHEMBL19397402

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5cccc6c5oc5ccccc56)cc4)nc(-c4cccc5ccccc45)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.50
ENPP3 O14638 1/20 0.41
ENPP1 P22413 1/20 0.41
ALDH1A1 P00352 6/20 0.41
HSD17B10 Q99714 5/20 0.41
KDM4E B2RXH2 5/20 0.41
MAPT P10636 5/20 0.41
HPGD P15428 5/20 0.41
MAPK1 P28482 4/20 0.41
ATM Q13315 3/20 0.41
TP53 P04637 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GGPS1 O95749 1/20 0.41
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397387 0.96 ALOX5 (0.48) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL19397621 0.95 ALOX5 (0.48) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL19397511 0.95 ALOX5 (0.51) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL19397381 0.95 ALOX5 (0.55) ALOX5ALDH1A1HSD17B10KDM4EMAPT
SCHEMBL15501712 0.94 ALOX5 (0.49) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL17899193 0.93 ALOX5 (0.48) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL19397608 0.93 ALOX5 (0.45) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL19397494 0.93 ALOX5 (0.48) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL15501821 0.93 ALOX5 (0.47) ALOX5ENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL17899181 0.93 ALOX5 (0.50) ALOX5ENPP3ENPP1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM ALOX5 2060/4885ENPP3 1308/4885ENPP1 1223/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 ALOX5 2055/4885ENPP3 1149/4885ENPP1 665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.